{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-215904","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2021-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.731463+00:00","generated_at":"2026-06-30T05:11:19.717065+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Clover Health CFO Joseph Wagner to step down Aug 13; Mark Herbers named interim CFO","bullets":["CFO Joseph Wagner departs Aug 13, 2021 for personal reasons; no disagreement with company.","Mark Herbers of AlixPartners appointed interim CFO effective Aug 13; permanent search underway.","Lee Shapiro (Audit Committee Chair) leads search committee; executive search firm engaged.","Wagner cites family health challenges; says decision not related to company operations or policies."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-215904","json":"https://secwatch.observer/filing/0001193125-21-215904.json","markdown":"https://secwatch.observer/filing/0001193125-21-215904.md","text":"https://secwatch.observer/filing/0001193125-21-215904.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000119312521215904/0001193125-21-215904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000119312521215904/d175914d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T05:11:19.717065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2eb468dcca","claim":"Mark Herbers was appointed as Interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"Effective upon the Departure Date, and until a permanent replacement for Mr. Wagner has been named, Mark Herbers will serve as the Company’s interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000119312521215904/0001193125-21-215904-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"491f369684","claim":"Joseph Wagner departed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"On July 15, 2021, Clover Health Investments, Corp. (the “Company”) announced that Joseph Wagner, the Company’s Chief Financial Officer, will be stepping down as an officer of the Company on August 13, 2021 (the “Departure Date”), following the filing of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the “Second Quarter 2021 Form 10-Q”), for personal reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000119312521215904/0001193125-21-215904-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepping down"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}